An in vitro study in hCAECs found that exenatide decreased inflammation by reducing activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B), adhesion molecules intracellular adhesion molecules (ICAM) and vascular cell adhesion molecules (VCAM), but not P-selectin (Garczorz et al., 2018)
These treatments can positively affect appetite, metabolism and overall cardiometabolic health, offering a meaningful approach to long-term management for the two diseases.How GLP-1 medications workGLP-1 receptor agonists increase hormones that help control hunger, satiety and blood sugar
Biochem Biophys Res Commun 459:574578
It should not rely on guarantees, dramatic before-and-after claims, influencer endorsements, or the phrase FDA approved when that status does not apply
*Not a guarantee of results